Clinical Study

Stroke Prevention Trial Comparing Rivaroxaban To Aspirin At Preventing Another Stroke In Patients Who Recently Had A Stroke Of Undetermined Cause.

Posted Date: Feb 22, 2017

  • Investigator: Dawn Kleindorfer
  • Co-Investigator: Omar Lopez
  • Specialties: Neurosurgery, Stroke, Neurology
  • Type of Study: Drug

The purpose of this study is to compare two drugs in preventing blood clots, rivaroxaban and aspirin. The study drug rivaroxaban/Xarelto® has not yet been approved by the Federal Drug Administration (FDA) for secondary prevention of blood clots in th


We Are Asking You To Take Part In This Research Study Because You Are 18 Years Of Age Or Older And You Have Recently Had A Brain Attack (Also Called A Stroke) Due To A Lack Of Blood Flow To Part Of Your Brain That May Have Been Caused By A Blood Clot. In


Cerebrovascular Accident, Rivaroxaban, Stroke, Blood Clot, Aspirin

For More Information:

Alisha Hodge, Rn, Bsn
(513) 558-5149

  • Search Clinical Studies

  • Research in the News

    Ride Cincinnati Gives $200,000 in Grants for Breast Cancer Research

    Marlene Harris-Ride Cincinnati has continued its support of UC Cancer Institutescientists with the annual award of five grants to continue promising breastcancer research.